文献速递胸部肿瘤放疗放疗物理与技术

肺癌患者CT通气成像与超极化3He磁共振成像的剂量功能指标一致性比较

Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized 3He Magnetic Resonance Imaging in Patients With Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-03-07

本研究纳入27例非小细胞肺癌患者,比较CT通气成像(CTVI)与超极化3He磁共振成像(MRI)在放疗计划中剂量功能指标(功能V20Gy和功能平均肺剂量)的一致性。结果显示两者相关系数为0.80至0.82,Bland-Altman分析显示功能V20Gy平均差异小于1%,95%一致性界限为8%至10%,表明患者间一致性存在差异。结论支持CTVI作为功能性避免放疗的通气替代指标。

要点

  • CTVI与3He MRI的剂量功能指标相关系数为0.80至0.82。
  • 功能V20Gy平均差异小于1%,95%一致性界限为8%至10%。
  • CTVI可作为功能性避免放疗的通气替代指标。

核心结论

  • CTVI与3He MRI在剂量功能指标上显示强相关和小偏差,支持CTVI作为功能性避免放疗的通气替代指标。

研究设计与样本

  • 本研究纳入27例非小细胞肺癌患者,患者来自一项评估3He MRI引导功能性避免放疗的2期随机试验。
  • 所有患者接受4维计算机断层扫描和3He MRI,CTVI回顾性创建,采用Pearson相关和Bland-Altman分析评估一致性。

主要发现

  • 功能V20Gy和功能平均肺剂量的相关系数均为0.80至0.82。
  • Bland-Altman分析显示功能V20Gy平均差异小于1%,95%一致性界限为8%至10%,表明患者间一致性存在差异。
  • 在可评估肺癌子量表(n=20)的患者中,下降≥3分的患者(n=8)功能V20Gy更高(CTVI:28.2% vs 21.9%,P=.05;3He MRI:26.2% vs 22.3%,P=.24)。
  • 发生≥2级放射性肺炎的患者(n=4)功能V20Gy也更高(CTVI:28.2% vs 24.2%,P=.34;3He MRI:27.0% vs 23.5%,P=.25)。

临床怎么用

  • CTVI与3He MRI剂量功能指标强相关且偏差小,可作为功能性避免放疗的通气替代指标用于临床。

局限性

  • 本研究为回顾性分析,样本量较小(27例),部分分析亚组样本量更小。
  • 剂量功能指标与临床结局的关联未显示统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Computed tomography ventilation imaging (CTVI) has great potential for clinical translation and has been validated in numerous studies. However, previous studies focused on image comparisons, and little is known about the dosimetric implications of "good" or "poor" image correlations or agreements in radiation therapy (RT). This study assessed the agreement of dose-function metrics between CTVI and hyperpolarized 3He magnetic resonance imaging (MRI) as a reference. METHODS AND MATERIALS: This study included 27 patients with non-small cell lung cancer who were randomized in a phase 2 trial examining 3He MRI-guided functional avoidance RT. All patients underwent 4-dimensional computed tomography and 3He MRI. CTVI was retrospectively created. Pearson correlation and Bland-Altman analyses were performed to assess the agreements between 3He MRI- and CTVI-based well-ventilated lung dose-function metrics, including functional V20Gy (fV20Gy) and functional mean lung dose, of RT plans. To assess the associations between dose-function metrics and clinical outcomes, we dichotomized patients by a clinically meaningful decline in Functional Assessment of Cancer Therapy-Lung: Lung Cancer Subscale (≥3-point) and the occurrence of grade ≥2 radiation pneumonitis and compared the dose-function metrics between the 2 groups. RESULTS: Correlation coefficients of dose-function metrics were 0.80 to 0.82 for both fV20Gy and functional mean lung dose. Bland-Altman analyses showed a mean difference < 1% for fV20Gy, with 95% limits of agreement of 8% to 10%, indicating that agreements varied among patients. Among Lung Cancer Subscale-evaluable patients (n = 20), those with a ≥3-point decline (n = 8) had higher fV20Gy than those without (CTVI: 28.2% vs 21.9%, P = .05; 3He MRI: 26.2% vs 22.3%, P = 0.24). Patients with grade ≥2 radiation pneumonitis (n = 4) also showed higher values than those without (CTVI: 28.2% vs 24.2%, P = .34; 3He MRI: 27.0% vs 23.5%, P = .25). CONCLUSIONS: CTVI demonstrated strong correlations and small bias in dose-function metrics with 3He MRI, including fV20Gy and functional mean lung dose. These findings support CTVI as a ventilation surrogate for functional avoidance RT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ito S, Nakajima Y, Fujita Y, et al. Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized 3He Magnetic Resonance Imaging in Patients With Lung Cancer. Int J Radiat Oncol Biol Phys. 2026. PMID: 41802548. doi:10.1016/j.ijrobp.2026.02.243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。